Patent applications published 2 November 2011
Selected patent applications from the weekly European Patents Bulletin
- Delayed release rasagiline formulation
Teva Pharmaceutical Industries 2381767*
- Process and intermediates for the preparation and intermediates of N-acylated-4-aryl beta-amino acid derivatives
Chiral Quest 2381772*
- Compsns for drug administration
Aegis Therapeutics 2381773*
- Method of treating neurodegenerative disease
Salk Institute for Biological Studies 2381774*
- Small molecule inhibitors of necroptosis
President and Fellows of Harvard College 2381775*
- Azaindole derivatives as kinase inhibitors
ARIAD Pharmaceuticals 2381776*
- C5AR antagonists
ChemoCentryx 2381778*
- Selective inhibitors of AKT and methods of using same
Sanford-Burnham Medical Research 2381779*
- Compsns comprising decitabine and tetrahydrouridine and uses thereof
The Board of Trustees of the University of Illinois 2381780*
- Labeling of target molecules, identification of organelles and other applications, novel compsns, methods and kits
Enzo Life Sciences 2381783*
- Nutritional intervention for improving muscular function and strength
Metabolic Technologies 2381784*
- Polymorphs of darunavir
Mapi Pharma 2381786*
- Targeted cryptosporidium biocides
Iogenetics; The Arizona Board of Regents On Behalf of the University of Arizona 2381788*
- Primed cell therapy
Tissuegene 2381789*
- Hydrogel compsn for the treatment of dermatological disorders
Intendis 2381916*
- Moisturising mixture, cosmetic and/or pharmaceutical compsns containing the moisturising mixture, use of the moisturising mixture, and cosmetic method
Natura Cosmeticos 2381917*
- Calcium sequestration compsns and methods of treating skin pigmentation disorders and conditions
Neocutis 2381918*
- Safe desmopressin administration
Allergan 2381923*
- Method for adding sensory conditioning cues in a pharmacotherapeutic regimen
Levine, Joshua; Levine, Robert 2381924*
- Pharmaceutical formulation of nanonised fenofibrate
Ethypharm 2381927*
- Process for the preparation of a peptide powder form
F Hoffmann-La Roche 2381928*
- Pharmaceutical compsns of lyophilised formulation and preparation method of same
Samyang 2381929*
- Active coating of pharmaceutical dosage forms
LEK Pharmaceuticals 2381930*
- Compsn including an active agent with low water solubility
Flamel Technologies 2381931*
- Intra-cervical device for the local release of drugs in the local-region treatment of cervical cancer
Fondazione IRCSS 2381932*
- Patch production technology
UCB Pharma 2381933*
- Improving cognitive function
Carmel - Haifa University Economic Group 2381934*
- Synergistic combinations of carotenoids and polyphenols
Lycored 2381935*
- Pathways to generate hair cells
Massachusetts Eye & Ear Infirmary 2381936*
- Opioid-containing oral pharmaceutical compsns and methods
Upsher-Smith Laboratories 2381937*
- A new family of pain producing substances and methods to produce novel analgesic drugs
Board of Regents, The University of Texas System 2381940*
- 3.1.0 bicyclic GLYT1 inhibitors and methods of making and using same
Vanderbilt University 2381941*
- Combination therapies for neoplastic disorders
Cylene Pharmaceuticals 2381942*
- Substituted quinazoline compounds
Fovea Pharmaceuticals 2381943*
- Anti-viral compounds, treatment, and assay
Southern Research Institute 2381944*
- Topical formulations of FLAP inhibitors for the treatment of dermatological conditions
Amira Pharmaceuticals 2381945*
- Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate
Teva Women’s Health 2381946*
- Mass spectrometry assay for oestrogenic compounds
Quest Diagnostics Investments 2381947*
- Compounds and methods for enhancing erythropoiesis
Wu, Sophia; Wu, Rong-Tsun 2381948*
- Immunostimulating saponins for use in in situ tumour-destruction therapy
Intervet International; Stichting Katholieke Universiteit 2381949*
- Compsns and methods of use
Vanas Oncology 2381950*
- Compsns and methods of treating viral infections
Life Science Nutrition 2381951*
- Sparc bringing peptides and uses thereof
Abraxis BioScience 2381952*
- Targeted antimicrobial moieties
C3 Jian 2381953*
- Methods and compsns based on shiga toxin type 2 protein
The Henry M Jackson Foundation for Advancement of Military Medicine 2381954*
- Combination therapies using NAP
Ramot at Tel-Aviv University; Allon Therapeutics 2381955*
- Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
Petrella, Robert 2381956*
- Therapeutic modulation of vaginal epithelium boundary lubrication
Singularis; Schepens Eye Research 2381957*
- Potato virus A coat protein-based vaccine for treating melanoma and its use
Tallinn University of Technology; University of Tartu 2381958*
- Stable vaccine compsns and methods of use
Pharmathene 2381959*
- Stable pharmaceutical compsn containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
Adocia 2381960*
- Implantable devices for treating HIV
Tibotec Pharmaceuticals 2381961*
- Compsn for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin
Universytet Jagiellonski 2381962*
- A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof
Meril Life Sciences Private 2381963*
- Synthesis of polymer conjugates and indocarbazole compounds
Creabilis 2381964*
- Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
Philadelphia Health and Education Corp; D/b/a Drexel University College of Medicine 2381965*
- Synthesis of 18F-radiolabelled styrylpyridines from tosylate precursors and stable pharmaceutical compsns thereof
Avid Radiopharmaceuticals 2381967*
- Biopolymeric membrane for wound protection and repair
Collagen Matrix 2381968*
- Wound dressings, methods and apparatus for making same and storage and use thereof
Kushnir, Alon; Kushnir, Igal 2381969*
- Silicate-substituted hydroxyapatite
The University Court of the University of Aberdeen 2381970*
- Tissue regeneration membrane
Hadasit Medical Research Services & Development; Yissum Research Development Company of the Hebrew University of Jerusalem 2381971*
- Drug delivery and substance transfer facilitated by nano-enhanced device having aligned carbon nanotubes protuding from device surface
California Institute of Technology 2381972*
- Infusion set with anaesthetic compound
Becton, Dickinson & Company 2381973*
- A method of forming and the resulting membrane compsn for surgical site preservation
Synthes 2381974*